The IXINITY Savings Program.*

    You can save up to $12,000 annually.

    Actual savings may vary depending on your individual health insurance coverage.

    If you have commercial health insurance, you can save up to $12,000 a year for your treatment with no income requirements or caps and no additional monthly limits.

    Starting the savings is easy.*

    CoPayCard_2024-1

    1. Have your IXINITY® prescription ready.
    2. Call Core Connections at 1-855-IXINITY (1-855-494-6489) to receive your savings card information e-mail.
    3. Give your savings card information to the pharmacy when you purchase IXINITY.

    See the IXINITY Savings Card Terms and Conditions below.

    NO LIMITS
    No OOP
    NO Requirements

       Program does not cover government healthcare costs (Medicare, Medicaid, and TRICARE) or costs associated with therapy administration. Actual savings may vary depending on your individual health insurance coverage. Other restrictions may apply, and a US prescriber and pharmacy are required. Medexus Pharma, Inc. reserves the right to rescind, revoke, or amend this offer without notice.

       May depend on your individual health insurance.

    IXINITY Savings Card Terms and Conditions:

    OFFER TERMS: By using the IXINITY Savings Card, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

    Offer only valid for patients with commercial prescription insurance. Offer not valid for prescriptions reimbursed under any federal or state healthcare program, including Medicare, Medicaid, or any state medical assistance programs. By using this card, the patient agrees not to submit a claim for reimbursement under any such program. Patient further agrees to comply with any terms of his or her health insurance contract requiring notification to his or her payor of the existence and/or value of this offer. Offer only valid in the USA. Offer void where prohibited by law, taxed, or restricted. It is illegal to sell (or offer to sell), purchase, or trade this card. Medexus Pharma, Inc. reserves the right to rescind, revoke, or amend this offer at any time without notice. Product dispenses only pursuant to program rules and federal and state laws. This is not insurance.

    INDICATIONS AND IMPORTANT SAFETY INFORMATION

    Expand

    What is IXINITY?

    IXINITY [coagulation factor IX (recombinant)] is a medicine used to replace clotting factor (factor IX) that is missing in adults and children with hemophilia B. Hemophilia B is also called congenital factor IX deficiency or Christmas disease. Hemophilia B is an inherited bleeding disorder that prevents clotting. For children and adults, your healthcare provider may give you IXINITY for on-demand treatment and control of bleeding episodes, when you have surgery, or for routine prophylaxis to prevent bleeding episodes.

    IXINITY is not indicated for induction of immune tolerance in patients with hemophilia B.

    IMPORTANT SAFETY INFORMATION for IXINITY

    • You should not use IXINITY if you are allergic to hamsters or any ingredients in IXINITY.

    • You should tell your healthcare provider if you have or have had medical problems, take any medicines, including prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies, have any allergies, including allergies to hamsters, are nursing, are pregnant or planning to become pregnant, or have been told that you have inhibitors to factor IX.

    • You can experience an allergic reaction to IXINITY. Contact your healthcare provider or get emergency treatment right away if you develop a rash or hives, itching, tightness of the throat, chest pain, or tightness, difficulty breathing, lightheadedness, dizziness, nausea, or fainting.

    • Your body may form inhibitors to IXINITY. An inhibitor is part of the body's defense system. If you develop inhibitors, it may prevent IXINITY from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for development of inhibitors to IXINITY.

    • If you have risk factors for developing blood clots, the use of IXINITY may increase the risk of abnormal blood clots.

    • Call your healthcare provider right away about any side effects that bother you or do not go away, or if your bleeding does not stop after taking IXINITY.

    • The most common side effect that was reported with IXINITY during clinical trials was headache.

    • These are not all the side effects possible with IXINITY. You can ask your healthcare provider for information that is written for healthcare professionals.


    For more information about IXINITY, please see full Prescribing Information.

    You are encouraged to report adverse events related to Medexus Pharma products by calling 1-844-859-6675. If you prefer, you may contact the Food and Drug Administration directly. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.